Date: July 09, 2026
Board Meeting Outcomes
- The company incorporated "ANLON MEDICARE PRIVATE LIMITED" (CIN: U21006GJ2026PTC180329) as a subsidiary effective July 09, 2026
- This action follows the company's earlier intimation dated July 01, 2026 regarding the proposal to incorporate a subsidiary
Financial Impact
- Total investment: ₹1,100,000 (Rupees Eleven Lakhs Only) paid through cash/banking channels
- Shareholding: 55% ownership through subscription of 110,000 equity shares of face value ₹10 each
- Subsidiary's authorized share capital: ₹5,000,000
- Subsidiary's paid-up share capital: ₹2,000,000
Strategic Purpose
- The subsidiary will manufacture surgical implants and medical devices
- Strategic objective: To complement and expand the company's existing business in the pain management segment
- Rationale: Leverage significant growth opportunities in the surgical implants and medical devices sector in India and international markets
Entity Details
- Subsidiary name: ANLON MEDICARE PRIVATE LIMITED
- Corporate Identification Number: U21006GJ2026PTC180329
- Country of incorporation: India
- Industry: Pharmaceuticals
- Date of incorporation: July 09, 2026
- Current turnover: Nil (newly incorporated company, yet to commence business)